nodes	percent_of_prediction	percent_of_DWPC	metapath
Nisoldipine—CYP1A2—Carmustine—lymphatic system cancer	0.134	0.182	CbGbCtD
Nisoldipine—CYP3A5—Teniposide—lymphatic system cancer	0.121	0.165	CbGbCtD
Nisoldipine—CYP3A7—Vincristine—lymphatic system cancer	0.0778	0.106	CbGbCtD
Nisoldipine—CYP3A7-CYP3A51P—Vincristine—lymphatic system cancer	0.0778	0.106	CbGbCtD
Nisoldipine—CYP3A5—Vincristine—lymphatic system cancer	0.0583	0.0792	CbGbCtD
Nisoldipine—ABCB1—Mitoxantrone—lymphatic system cancer	0.0552	0.0749	CbGbCtD
Nisoldipine—CYP3A4—Cytarabine—lymphatic system cancer	0.048	0.0651	CbGbCtD
Nisoldipine—CYP3A4—Teniposide—lymphatic system cancer	0.0473	0.0642	CbGbCtD
Nisoldipine—ABCB1—Vincristine—lymphatic system cancer	0.038	0.0515	CbGbCtD
Nisoldipine—CYP3A4—Mitoxantrone—lymphatic system cancer	0.033	0.0449	CbGbCtD
Nisoldipine—ABCB1—Methotrexate—lymphatic system cancer	0.023	0.0312	CbGbCtD
Nisoldipine—CYP3A4—Vincristine—lymphatic system cancer	0.0227	0.0309	CbGbCtD
Nisoldipine—Anaemia—Fludarabine—lymphatic system cancer	0.00102	0.00388	CcSEcCtD
Nisoldipine—Myocardial infarction—Bleomycin—lymphatic system cancer	0.00102	0.00386	CcSEcCtD
Nisoldipine—Dysphagia—Carmustine—lymphatic system cancer	0.00102	0.00386	CcSEcCtD
Nisoldipine—Stomatitis—Bleomycin—lymphatic system cancer	0.00101	0.00384	CcSEcCtD
Nisoldipine—Tachycardia—Teniposide—lymphatic system cancer	0.001	0.00381	CcSEcCtD
Nisoldipine—Malaise—Fludarabine—lymphatic system cancer	0.000998	0.00379	CcSEcCtD
Nisoldipine—Herpes zoster—Methotrexate—lymphatic system cancer	0.000997	0.00378	CcSEcCtD
Nisoldipine—Hypokalaemia—Mitoxantrone—lymphatic system cancer	0.000995	0.00378	CcSEcCtD
Nisoldipine—Hyperhidrosis—Teniposide—lymphatic system cancer	0.000994	0.00377	CcSEcCtD
Nisoldipine—Leukopenia—Fludarabine—lymphatic system cancer	0.000991	0.00376	CcSEcCtD
Nisoldipine—Muscular weakness—Vincristine—lymphatic system cancer	0.00099	0.00376	CcSEcCtD
Nisoldipine—Haematuria—Bleomycin—lymphatic system cancer	0.00099	0.00376	CcSEcCtD
Nisoldipine—Pruritus—Mechlorethamine—lymphatic system cancer	0.000986	0.00374	CcSEcCtD
Nisoldipine—Pleural effusion—Methotrexate—lymphatic system cancer	0.00098	0.00372	CcSEcCtD
Nisoldipine—Anorexia—Teniposide—lymphatic system cancer	0.00098	0.00372	CcSEcCtD
Nisoldipine—Cough—Fludarabine—lymphatic system cancer	0.000966	0.00366	CcSEcCtD
Nisoldipine—Skin ulcer—Methotrexate—lymphatic system cancer	0.000964	0.00366	CcSEcCtD
Nisoldipine—Hypotension—Teniposide—lymphatic system cancer	0.000961	0.00364	CcSEcCtD
Nisoldipine—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.000954	0.00362	CcSEcCtD
Nisoldipine—Myalgia—Fludarabine—lymphatic system cancer	0.000942	0.00357	CcSEcCtD
Nisoldipine—Arthralgia—Fludarabine—lymphatic system cancer	0.000942	0.00357	CcSEcCtD
Nisoldipine—Discomfort—Fludarabine—lymphatic system cancer	0.000931	0.00353	CcSEcCtD
Nisoldipine—Hypoaesthesia—Bleomycin—lymphatic system cancer	0.000928	0.00352	CcSEcCtD
Nisoldipine—Dyspnoea—Teniposide—lymphatic system cancer	0.000916	0.00348	CcSEcCtD
Nisoldipine—Petechiae—Methotrexate—lymphatic system cancer	0.000912	0.00346	CcSEcCtD
Nisoldipine—Confusional state—Fludarabine—lymphatic system cancer	0.000911	0.00346	CcSEcCtD
Nisoldipine—Dysuria—Vincristine—lymphatic system cancer	0.000908	0.00344	CcSEcCtD
Nisoldipine—Oedema—Fludarabine—lymphatic system cancer	0.000903	0.00343	CcSEcCtD
Nisoldipine—Erectile dysfunction—Vincristine—lymphatic system cancer	0.000894	0.00339	CcSEcCtD
Nisoldipine—Decreased appetite—Teniposide—lymphatic system cancer	0.000894	0.00339	CcSEcCtD
Nisoldipine—Stomatitis—Carmustine—lymphatic system cancer	0.000884	0.00335	CcSEcCtD
Nisoldipine—Rash—Mechlorethamine—lymphatic system cancer	0.000879	0.00333	CcSEcCtD
Nisoldipine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.000878	0.00333	CcSEcCtD
Nisoldipine—Weight decreased—Vincristine—lymphatic system cancer	0.000878	0.00333	CcSEcCtD
Nisoldipine—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.000873	0.00331	CcSEcCtD
Nisoldipine—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.000871	0.0033	CcSEcCtD
Nisoldipine—Anorexia—Fludarabine—lymphatic system cancer	0.000861	0.00327	CcSEcCtD
Nisoldipine—Weight increased—Mitoxantrone—lymphatic system cancer	0.00086	0.00326	CcSEcCtD
Nisoldipine—Weight decreased—Mitoxantrone—lymphatic system cancer	0.000855	0.00324	CcSEcCtD
Nisoldipine—Acute coronary syndrome—Vincristine—lymphatic system cancer	0.000853	0.00324	CcSEcCtD
Nisoldipine—Myocardial infarction—Vincristine—lymphatic system cancer	0.000848	0.00322	CcSEcCtD
Nisoldipine—Feeling abnormal—Teniposide—lymphatic system cancer	0.000847	0.00321	CcSEcCtD
Nisoldipine—Stomatitis—Vincristine—lymphatic system cancer	0.000844	0.0032	CcSEcCtD
Nisoldipine—Chills—Bleomycin—lymphatic system cancer	0.000837	0.00317	CcSEcCtD
Nisoldipine—Skin discolouration—Methotrexate—lymphatic system cancer	0.000831	0.00315	CcSEcCtD
Nisoldipine—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.000831	0.00315	CcSEcCtD
Nisoldipine—Sweating—Vincristine—lymphatic system cancer	0.00083	0.00315	CcSEcCtD
Nisoldipine—Nausea—Mechlorethamine—lymphatic system cancer	0.000828	0.00314	CcSEcCtD
Nisoldipine—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.000826	0.00313	CcSEcCtD
Nisoldipine—Alopecia—Bleomycin—lymphatic system cancer	0.000824	0.00313	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.000823	0.00312	CcSEcCtD
Nisoldipine—Stomatitis—Mitoxantrone—lymphatic system cancer	0.000822	0.00312	CcSEcCtD
Nisoldipine—Conjunctivitis—Mitoxantrone—lymphatic system cancer	0.000819	0.00311	CcSEcCtD
Nisoldipine—Urticaria—Teniposide—lymphatic system cancer	0.000817	0.0031	CcSEcCtD
Nisoldipine—Herpes simplex—Methotrexate—lymphatic system cancer	0.000815	0.00309	CcSEcCtD
Nisoldipine—Glossitis—Methotrexate—lymphatic system cancer	0.000815	0.00309	CcSEcCtD
Nisoldipine—Body temperature increased—Teniposide—lymphatic system cancer	0.000813	0.00308	CcSEcCtD
Nisoldipine—Paraesthesia—Fludarabine—lymphatic system cancer	0.000811	0.00308	CcSEcCtD
Nisoldipine—Hypoaesthesia—Carmustine—lymphatic system cancer	0.00081	0.00307	CcSEcCtD
Nisoldipine—Sweating—Mitoxantrone—lymphatic system cancer	0.000808	0.00306	CcSEcCtD
Nisoldipine—Dyspnoea—Fludarabine—lymphatic system cancer	0.000805	0.00306	CcSEcCtD
Nisoldipine—Haematuria—Mitoxantrone—lymphatic system cancer	0.000804	0.00305	CcSEcCtD
Nisoldipine—Oedema peripheral—Carmustine—lymphatic system cancer	0.000802	0.00304	CcSEcCtD
Nisoldipine—Dyspepsia—Fludarabine—lymphatic system cancer	0.000795	0.00302	CcSEcCtD
Nisoldipine—Sinusitis—Mitoxantrone—lymphatic system cancer	0.000791	0.003	CcSEcCtD
Nisoldipine—Decreased appetite—Fludarabine—lymphatic system cancer	0.000785	0.00298	CcSEcCtD
Nisoldipine—Visual impairment—Carmustine—lymphatic system cancer	0.000784	0.00298	CcSEcCtD
Nisoldipine—Hypoaesthesia—Vincristine—lymphatic system cancer	0.000773	0.00293	CcSEcCtD
Nisoldipine—Rhinitis—Mitoxantrone—lymphatic system cancer	0.000759	0.00288	CcSEcCtD
Nisoldipine—Hypersensitivity—Teniposide—lymphatic system cancer	0.000757	0.00287	CcSEcCtD
Nisoldipine—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.000753	0.00286	CcSEcCtD
Nisoldipine—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.000751	0.00285	CcSEcCtD
Nisoldipine—Vaginal inflammation—Methotrexate—lymphatic system cancer	0.000751	0.00285	CcSEcCtD
Nisoldipine—Anaemia—Bleomycin—lymphatic system cancer	0.00075	0.00285	CcSEcCtD
Nisoldipine—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000744	0.00282	CcSEcCtD
Nisoldipine—Melaena—Methotrexate—lymphatic system cancer	0.000733	0.00278	CcSEcCtD
Nisoldipine—Malaise—Bleomycin—lymphatic system cancer	0.000732	0.00278	CcSEcCtD
Nisoldipine—Pruritus—Teniposide—lymphatic system cancer	0.000727	0.00276	CcSEcCtD
Nisoldipine—Leukopenia—Bleomycin—lymphatic system cancer	0.000727	0.00276	CcSEcCtD
Nisoldipine—Alopecia—Carmustine—lymphatic system cancer	0.000719	0.00273	CcSEcCtD
Nisoldipine—Body temperature increased—Fludarabine—lymphatic system cancer	0.000714	0.00271	CcSEcCtD
Nisoldipine—Vaginal infection—Methotrexate—lymphatic system cancer	0.000709	0.00269	CcSEcCtD
Nisoldipine—Cough—Bleomycin—lymphatic system cancer	0.000708	0.00269	CcSEcCtD
Nisoldipine—Diarrhoea—Teniposide—lymphatic system cancer	0.000703	0.00267	CcSEcCtD
Nisoldipine—Myalgia—Bleomycin—lymphatic system cancer	0.000691	0.00262	CcSEcCtD
Nisoldipine—Chest pain—Bleomycin—lymphatic system cancer	0.000691	0.00262	CcSEcCtD
Nisoldipine—Alopecia—Vincristine—lymphatic system cancer	0.000687	0.0026	CcSEcCtD
Nisoldipine—Discomfort—Bleomycin—lymphatic system cancer	0.000683	0.00259	CcSEcCtD
Nisoldipine—Chills—Mitoxantrone—lymphatic system cancer	0.000679	0.00258	CcSEcCtD
Nisoldipine—Mouth ulceration—Methotrexate—lymphatic system cancer	0.000679	0.00257	CcSEcCtD
Nisoldipine—Ecchymosis—Methotrexate—lymphatic system cancer	0.000679	0.00257	CcSEcCtD
Nisoldipine—Gynaecomastia—Methotrexate—lymphatic system cancer	0.000672	0.00255	CcSEcCtD
Nisoldipine—Alopecia—Mitoxantrone—lymphatic system cancer	0.000669	0.00254	CcSEcCtD
Nisoldipine—Confusional state—Bleomycin—lymphatic system cancer	0.000668	0.00253	CcSEcCtD
Nisoldipine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000666	0.00252	CcSEcCtD
Nisoldipine—Tremor—Carmustine—lymphatic system cancer	0.000664	0.00252	CcSEcCtD
Nisoldipine—Oedema—Bleomycin—lymphatic system cancer	0.000662	0.00251	CcSEcCtD
Nisoldipine—Anaemia—Carmustine—lymphatic system cancer	0.000655	0.00248	CcSEcCtD
Nisoldipine—Rash—Teniposide—lymphatic system cancer	0.000648	0.00246	CcSEcCtD
Nisoldipine—Dermatitis—Teniposide—lymphatic system cancer	0.000648	0.00246	CcSEcCtD
Nisoldipine—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000645	0.00245	CcSEcCtD
Nisoldipine—Headache—Teniposide—lymphatic system cancer	0.000644	0.00244	CcSEcCtD
Nisoldipine—Pruritus—Fludarabine—lymphatic system cancer	0.000639	0.00242	CcSEcCtD
Nisoldipine—Leukopenia—Carmustine—lymphatic system cancer	0.000634	0.00241	CcSEcCtD
Nisoldipine—Anorexia—Bleomycin—lymphatic system cancer	0.000631	0.0024	CcSEcCtD
Nisoldipine—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.000626	0.00238	CcSEcCtD
Nisoldipine—Anaemia—Vincristine—lymphatic system cancer	0.000625	0.00237	CcSEcCtD
Nisoldipine—Hypotension—Bleomycin—lymphatic system cancer	0.000619	0.00235	CcSEcCtD
Nisoldipine—Diarrhoea—Fludarabine—lymphatic system cancer	0.000618	0.00234	CcSEcCtD
Nisoldipine—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000611	0.00232	CcSEcCtD
Nisoldipine—Nausea—Teniposide—lymphatic system cancer	0.000611	0.00232	CcSEcCtD
Nisoldipine—Anaemia—Mitoxantrone—lymphatic system cancer	0.000609	0.00231	CcSEcCtD
Nisoldipine—Vertigo—Vincristine—lymphatic system cancer	0.000608	0.0023	CcSEcCtD
Nisoldipine—Leukopenia—Vincristine—lymphatic system cancer	0.000605	0.0023	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000603	0.00229	CcSEcCtD
Nisoldipine—Chest pain—Carmustine—lymphatic system cancer	0.000603	0.00229	CcSEcCtD
Nisoldipine—Myalgia—Carmustine—lymphatic system cancer	0.000603	0.00229	CcSEcCtD
Nisoldipine—Anxiety—Carmustine—lymphatic system cancer	0.000601	0.00228	CcSEcCtD
Nisoldipine—Paraesthesia—Bleomycin—lymphatic system cancer	0.000595	0.00226	CcSEcCtD
Nisoldipine—Malaise—Mitoxantrone—lymphatic system cancer	0.000594	0.00225	CcSEcCtD
Nisoldipine—Dyspnoea—Bleomycin—lymphatic system cancer	0.000591	0.00224	CcSEcCtD
Nisoldipine—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00059	0.00224	CcSEcCtD
Nisoldipine—Confusional state—Carmustine—lymphatic system cancer	0.000583	0.00221	CcSEcCtD
Nisoldipine—Oedema—Carmustine—lymphatic system cancer	0.000578	0.00219	CcSEcCtD
Nisoldipine—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.000577	0.00219	CcSEcCtD
Nisoldipine—Decreased appetite—Bleomycin—lymphatic system cancer	0.000576	0.00218	CcSEcCtD
Nisoldipine—Myalgia—Vincristine—lymphatic system cancer	0.000576	0.00218	CcSEcCtD
Nisoldipine—Cough—Mitoxantrone—lymphatic system cancer	0.000575	0.00218	CcSEcCtD
Nisoldipine—Rash—Fludarabine—lymphatic system cancer	0.00057	0.00216	CcSEcCtD
Nisoldipine—Dermatitis—Fludarabine—lymphatic system cancer	0.000569	0.00216	CcSEcCtD
Nisoldipine—Headache—Fludarabine—lymphatic system cancer	0.000566	0.00215	CcSEcCtD
Nisoldipine—Tachycardia—Carmustine—lymphatic system cancer	0.000564	0.00214	CcSEcCtD
Nisoldipine—Myalgia—Mitoxantrone—lymphatic system cancer	0.000561	0.00213	CcSEcCtD
Nisoldipine—Chest pain—Mitoxantrone—lymphatic system cancer	0.000561	0.00213	CcSEcCtD
Nisoldipine—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000561	0.00213	CcSEcCtD
Nisoldipine—Anxiety—Mitoxantrone—lymphatic system cancer	0.000559	0.00212	CcSEcCtD
Nisoldipine—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.000556	0.00211	CcSEcCtD
Nisoldipine—Discomfort—Mitoxantrone—lymphatic system cancer	0.000554	0.0021	CcSEcCtD
Nisoldipine—Oedema—Vincristine—lymphatic system cancer	0.000552	0.00209	CcSEcCtD
Nisoldipine—Anorexia—Carmustine—lymphatic system cancer	0.000551	0.00209	CcSEcCtD
Nisoldipine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000546	0.00207	CcSEcCtD
Nisoldipine—Confusional state—Mitoxantrone—lymphatic system cancer	0.000542	0.00206	CcSEcCtD
Nisoldipine—Hypotension—Carmustine—lymphatic system cancer	0.00054	0.00205	CcSEcCtD
Nisoldipine—Oedema—Mitoxantrone—lymphatic system cancer	0.000538	0.00204	CcSEcCtD
Nisoldipine—Nausea—Fludarabine—lymphatic system cancer	0.000537	0.00204	CcSEcCtD
Nisoldipine—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000534	0.00202	CcSEcCtD
Nisoldipine—Shock—Mitoxantrone—lymphatic system cancer	0.000529	0.00201	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000527	0.002	CcSEcCtD
Nisoldipine—Urticaria—Bleomycin—lymphatic system cancer	0.000526	0.002	CcSEcCtD
Nisoldipine—Anorexia—Vincristine—lymphatic system cancer	0.000526	0.002	CcSEcCtD
Nisoldipine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000525	0.00199	CcSEcCtD
Nisoldipine—Body temperature increased—Bleomycin—lymphatic system cancer	0.000524	0.00199	CcSEcCtD
Nisoldipine—Insomnia—Carmustine—lymphatic system cancer	0.000523	0.00198	CcSEcCtD
Nisoldipine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00052	0.00197	CcSEcCtD
Nisoldipine—Paraesthesia—Carmustine—lymphatic system cancer	0.000519	0.00197	CcSEcCtD
Nisoldipine—Hypotension—Vincristine—lymphatic system cancer	0.000516	0.00196	CcSEcCtD
Nisoldipine—Dyspnoea—Carmustine—lymphatic system cancer	0.000515	0.00196	CcSEcCtD
Nisoldipine—Somnolence—Carmustine—lymphatic system cancer	0.000514	0.00195	CcSEcCtD
Nisoldipine—Anorexia—Mitoxantrone—lymphatic system cancer	0.000512	0.00194	CcSEcCtD
Nisoldipine—Ataxia—Methotrexate—lymphatic system cancer	0.000512	0.00194	CcSEcCtD
Nisoldipine—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000503	0.00191	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000503	0.00191	CcSEcCtD
Nisoldipine—Decreased appetite—Carmustine—lymphatic system cancer	0.000503	0.00191	CcSEcCtD
Nisoldipine—Hypotension—Mitoxantrone—lymphatic system cancer	0.000502	0.00191	CcSEcCtD
Nisoldipine—Insomnia—Vincristine—lymphatic system cancer	0.000499	0.00189	CcSEcCtD
Nisoldipine—Paraesthesia—Vincristine—lymphatic system cancer	0.000496	0.00188	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00049	0.00186	CcSEcCtD
Nisoldipine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000488	0.00185	CcSEcCtD
Nisoldipine—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000483	0.00183	CcSEcCtD
Nisoldipine—Decreased appetite—Vincristine—lymphatic system cancer	0.00048	0.00182	CcSEcCtD
Nisoldipine—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000479	0.00182	CcSEcCtD
Nisoldipine—Somnolence—Mitoxantrone—lymphatic system cancer	0.000478	0.00181	CcSEcCtD
Nisoldipine—Feeling abnormal—Carmustine—lymphatic system cancer	0.000476	0.00181	CcSEcCtD
Nisoldipine—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000473	0.00179	CcSEcCtD
Nisoldipine—Asthma—Methotrexate—lymphatic system cancer	0.000471	0.00179	CcSEcCtD
Nisoldipine—Pruritus—Bleomycin—lymphatic system cancer	0.000469	0.00178	CcSEcCtD
Nisoldipine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000467	0.00177	CcSEcCtD
Nisoldipine—Body temperature increased—Carmustine—lymphatic system cancer	0.000457	0.00173	CcSEcCtD
Nisoldipine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000443	0.00168	CcSEcCtD
Nisoldipine—Dysuria—Methotrexate—lymphatic system cancer	0.00044	0.00167	CcSEcCtD
Nisoldipine—Body temperature increased—Vincristine—lymphatic system cancer	0.000436	0.00166	CcSEcCtD
Nisoldipine—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000434	0.00165	CcSEcCtD
Nisoldipine—Urticaria—Mitoxantrone—lymphatic system cancer	0.000427	0.00162	CcSEcCtD
Nisoldipine—Hypersensitivity—Carmustine—lymphatic system cancer	0.000426	0.00162	CcSEcCtD
Nisoldipine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000425	0.00161	CcSEcCtD
Nisoldipine—Rash—Bleomycin—lymphatic system cancer	0.000418	0.00158	CcSEcCtD
Nisoldipine—Dermatitis—Bleomycin—lymphatic system cancer	0.000417	0.00158	CcSEcCtD
Nisoldipine—Stomatitis—Methotrexate—lymphatic system cancer	0.000409	0.00155	CcSEcCtD
Nisoldipine—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000408	0.00155	CcSEcCtD
Nisoldipine—Hypersensitivity—Vincristine—lymphatic system cancer	0.000407	0.00154	CcSEcCtD
Nisoldipine—Sweating—Methotrexate—lymphatic system cancer	0.000403	0.00153	CcSEcCtD
Nisoldipine—Haematuria—Methotrexate—lymphatic system cancer	0.0004	0.00152	CcSEcCtD
Nisoldipine—Epistaxis—Methotrexate—lymphatic system cancer	0.000396	0.0015	CcSEcCtD
Nisoldipine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000396	0.0015	CcSEcCtD
Nisoldipine—Diarrhoea—Carmustine—lymphatic system cancer	0.000396	0.0015	CcSEcCtD
Nisoldipine—Nausea—Bleomycin—lymphatic system cancer	0.000393	0.00149	CcSEcCtD
Nisoldipine—Dizziness—Carmustine—lymphatic system cancer	0.000382	0.00145	CcSEcCtD
Nisoldipine—Diarrhoea—Vincristine—lymphatic system cancer	0.000378	0.00143	CcSEcCtD
Nisoldipine—Pharyngitis—Methotrexate—lymphatic system cancer	0.000374	0.00142	CcSEcCtD
Nisoldipine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000368	0.0014	CcSEcCtD
Nisoldipine—Dizziness—Vincristine—lymphatic system cancer	0.000365	0.00138	CcSEcCtD
Nisoldipine—Rash—Carmustine—lymphatic system cancer	0.000365	0.00138	CcSEcCtD
Nisoldipine—Dermatitis—Carmustine—lymphatic system cancer	0.000364	0.00138	CcSEcCtD
Nisoldipine—Visual impairment—Methotrexate—lymphatic system cancer	0.000363	0.00138	CcSEcCtD
Nisoldipine—Headache—Carmustine—lymphatic system cancer	0.000362	0.00137	CcSEcCtD
Nisoldipine—Tinnitus—Methotrexate—lymphatic system cancer	0.000351	0.00133	CcSEcCtD
Nisoldipine—Rash—Vincristine—lymphatic system cancer	0.000348	0.00132	CcSEcCtD
Nisoldipine—Dermatitis—Vincristine—lymphatic system cancer	0.000348	0.00132	CcSEcCtD
Nisoldipine—Headache—Vincristine—lymphatic system cancer	0.000346	0.00131	CcSEcCtD
Nisoldipine—Nausea—Carmustine—lymphatic system cancer	0.000343	0.0013	CcSEcCtD
Nisoldipine—Rash—Mitoxantrone—lymphatic system cancer	0.000339	0.00129	CcSEcCtD
Nisoldipine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000339	0.00128	CcSEcCtD
Nisoldipine—Chills—Methotrexate—lymphatic system cancer	0.000338	0.00128	CcSEcCtD
Nisoldipine—Headache—Mitoxantrone—lymphatic system cancer	0.000337	0.00128	CcSEcCtD
Nisoldipine—Alopecia—Methotrexate—lymphatic system cancer	0.000333	0.00126	CcSEcCtD
Nisoldipine—Nausea—Vincristine—lymphatic system cancer	0.000328	0.00124	CcSEcCtD
Nisoldipine—Dysgeusia—Methotrexate—lymphatic system cancer	0.000321	0.00122	CcSEcCtD
Nisoldipine—Nausea—Mitoxantrone—lymphatic system cancer	0.000319	0.00121	CcSEcCtD
Nisoldipine—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000304	0.00115	CcSEcCtD
Nisoldipine—Anaemia—Methotrexate—lymphatic system cancer	0.000303	0.00115	CcSEcCtD
Nisoldipine—Malaise—Methotrexate—lymphatic system cancer	0.000296	0.00112	CcSEcCtD
Nisoldipine—Vertigo—Methotrexate—lymphatic system cancer	0.000295	0.00112	CcSEcCtD
Nisoldipine—Leukopenia—Methotrexate—lymphatic system cancer	0.000294	0.00111	CcSEcCtD
Nisoldipine—Cough—Methotrexate—lymphatic system cancer	0.000286	0.00109	CcSEcCtD
Nisoldipine—Chest pain—Methotrexate—lymphatic system cancer	0.000279	0.00106	CcSEcCtD
Nisoldipine—Myalgia—Methotrexate—lymphatic system cancer	0.000279	0.00106	CcSEcCtD
Nisoldipine—Arthralgia—Methotrexate—lymphatic system cancer	0.000279	0.00106	CcSEcCtD
Nisoldipine—Discomfort—Methotrexate—lymphatic system cancer	0.000276	0.00105	CcSEcCtD
Nisoldipine—Confusional state—Methotrexate—lymphatic system cancer	0.00027	0.00102	CcSEcCtD
Nisoldipine—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000259	0.000982	CcSEcCtD
Nisoldipine—Anorexia—Methotrexate—lymphatic system cancer	0.000255	0.000968	CcSEcCtD
Nisoldipine—Hypotension—Methotrexate—lymphatic system cancer	0.00025	0.000949	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000244	0.000926	CcSEcCtD
Nisoldipine—Insomnia—Methotrexate—lymphatic system cancer	0.000242	0.000919	CcSEcCtD
Nisoldipine—Paraesthesia—Methotrexate—lymphatic system cancer	0.00024	0.000912	CcSEcCtD
Nisoldipine—Dyspnoea—Methotrexate—lymphatic system cancer	0.000239	0.000906	CcSEcCtD
Nisoldipine—Somnolence—Methotrexate—lymphatic system cancer	0.000238	0.000903	CcSEcCtD
Nisoldipine—Dyspepsia—Methotrexate—lymphatic system cancer	0.000236	0.000894	CcSEcCtD
Nisoldipine—Decreased appetite—Methotrexate—lymphatic system cancer	0.000233	0.000883	CcSEcCtD
Nisoldipine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000221	0.000837	CcSEcCtD
Nisoldipine—Urticaria—Methotrexate—lymphatic system cancer	0.000213	0.000807	CcSEcCtD
Nisoldipine—Body temperature increased—Methotrexate—lymphatic system cancer	0.000212	0.000803	CcSEcCtD
Nisoldipine—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000197	0.000748	CcSEcCtD
Nisoldipine—Pruritus—Methotrexate—lymphatic system cancer	0.000189	0.000719	CcSEcCtD
Nisoldipine—Diarrhoea—Methotrexate—lymphatic system cancer	0.000183	0.000695	CcSEcCtD
Nisoldipine—Dizziness—Methotrexate—lymphatic system cancer	0.000177	0.000672	CcSEcCtD
Nisoldipine—Rash—Methotrexate—lymphatic system cancer	0.000169	0.000641	CcSEcCtD
Nisoldipine—Dermatitis—Methotrexate—lymphatic system cancer	0.000169	0.00064	CcSEcCtD
Nisoldipine—Headache—Methotrexate—lymphatic system cancer	0.000168	0.000636	CcSEcCtD
Nisoldipine—Nausea—Methotrexate—lymphatic system cancer	0.000159	0.000603	CcSEcCtD
